Evidence map›Paper›PMID 32616888›Full record

ArticleOncogene2020

Melanoma stem cell maintenance and chemo-resistance are mediated by CD133 signal to PI3K-dependent pathways.

Siraj M El Jamal, Abdulhadi Alamodi, Renate U Wahl, Zakaria Grada, Mohammad Abrar Shareef, Sofie-Yasmin Hassan, Fadi Murad, Sarah-Lilly Hassan, Simeon Santourlidis, Christian R Gomez and 3 more

Abstract read
PubMed Publisher
In one paragraph

Article in Oncogene, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 51 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Review
  15. Review
  16. Review
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 10 institutions in 4 countries.

Siraj M El Jamal *Department of Pathology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Abdulhadi Alamodi *School of public health, Jackson State University, Jackson, MS, USA.
Renate U Wahl *Clinic of Dermatology, University Hospital of Aachen, Aachen, Germany.ORCID http://orcid.org/0000-0003-1748-3689
Zakaria GradaDepartment of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
Mohammad Abrar ShareefDepartment of Internal Medicine, Eastern Maine Medical Center, Bangor, ME, USA.ORCID http://orcid.org/0000-0002-9699-4884
Sofie-Yasmin HassanClinic of Dermatology, University Hospital of Aachen, Aachen, Germany.
Fadi MuradDepartment of Epidemiology, Bloomberg School of Public Health, Baltimore, MD, USA.
Sarah-Lilly HassanClinic of Dermatology, University Hospital of Aachen, Aachen, Germany.
Simeon SantourlidisMedical Faculty, Epigenetics Core Laboratory, Institute of Transplantation Diagnostics and Cell Therapeutics, Heinrich-Heine University Duesseldorf, Duesseldorf, Germany.
Christian R GomezDepartment of Pathology, University of Mississippi Medical Center, Jackson, MS, USA.
Youssef HaikelInstitut National de la Santé et de la Recherche Médicale, Strasbourg, France.
Mosaad MegahedClinic of Dermatology, University Hospital of Aachen, Aachen, Germany.
Mohamed HassanInstitut National de la Santé et de la Recherche Médicale, Strasbourg, France. dr.hassan@gmx.de.ORCID http://orcid.org/0000-0002-0336-6425
Universitätsklinikum Aachen · DEBeth Israel Deaconess Medical Center · USEastern Maine Medical Center · USHeinrich Heine University Düsseldorf · DEIcahn School of Medicine at Mount Sinai · USInserm · FRJackson Memorial Hospital · USJackson State University · USJohns Hopkins University · USTulane University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Melanoma stem cells (MSCs) are characterized by their unique cell surface proteins and aberrant signaling pathways. These stemness properties are either in a causal or consequential relationship to melanoma progression, treatment resistance and recurrence. The functional analysis of CD133

Indexed as

AC133 AntigenAntineoplastic AgentsCell Line, TumorDrug Resistance, NeoplasmDual Specificity Phosphatase 1HumansMelanomaNitrosourea CompoundsOrganophosphorus CompoundsPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-mdm2Signal TransductionStem CellsAC133 AntigenAntineoplastic AgentsDual Specificity Phosphatase 1DUSP1 protein, humanfotemustineMDM2 protein, humanNitrosourea CompoundsOrganophosphorus CompoundsPhosphatidylinositol 3-KinasesPROM1 protein, humanProto-Oncogene Proteins c-mdm2

Identifiers

PMID32616888
OpenAlexW3040197305

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.